Loading...
Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations
SIMPLE SUMMARY: Polycythemia vera (PV) is a chronic blood disease characterized by elevated red blood cells and splenomegaly. About 98% of all PV patients harbor the JAK2 mutation. Ruxolitinib (RUX), a JAK1/JAK2 inhibitor, received approval as a second-line indication in PV patients who are resistan...
Saved in:
| Published in: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693745/ https://ncbi.nlm.nih.gov/pubmed/33114733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113132 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|